Diseases & Disorders
(G30)
990 on File
THE MARK FOUNDATION FOR CANCER RESEARCH US LTD
Financial strength (30%)
86/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$44.8M
Total Revenue
$36.1M
Total Expenses
$92.4M
Net Assets
9
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
94.0%
Fundraising Efficiency
N/A
Operating Reserve
30.76x
Liability-to-Asset
12.4%
Revenue Diversification
99.2%
Executive Compensation
$1.7M
Compared with Peers
FY 2024
Compared with 166 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
94.0% | 86.7% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.2% | 10.3% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
2.8% | 0.5% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
30.8 mo | 7.8 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
12.4% | 28.9% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.2% | 90.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
9.4% | 7.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
2.4% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
19.4% | 1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $44.8M | $36.1M | $92.4M | 94.0% | 9 |
| 2023 | $40.9M | $35.2M | $84.5M | 94.7% | 11 |
| 2022 | $55.3M | $38.0M | $82.5M | 95.0% | 9 |
| 2021 | $37.5M | $35.7M | N/A | — | 13 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.